These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 18981733)

  • 1. Cancer cell killing via ROS: to increase or decrease, that is the question.
    Wang J; Yi J
    Cancer Biol Ther; 2008 Dec; 7(12):1875-84. PubMed ID: 18981733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive oxygen species in cancer biology and anticancer therapy.
    Yang Y; Karakhanova S; Werner J; Bazhin AV
    Curr Med Chem; 2013; 20(30):3677-92. PubMed ID: 23862622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies.
    Li J; Lim JYS; Eu JQ; Chan AKMH; Goh BC; Wang L; Wong AL
    Antioxid Redox Signal; 2024 Aug; 41(4-6):322-341. PubMed ID: 38445392
    [No Abstract]   [Full Text] [Related]  

  • 4. Reactive oxygen species in redox cancer therapy.
    Tong L; Chuang CC; Wu S; Zuo L
    Cancer Lett; 2015 Oct; 367(1):18-25. PubMed ID: 26187782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The redox-active nanomaterial toolbox for cancer therapy.
    Ibañez IL; Notcovich C; Catalano PN; Bellino MG; Durán H
    Cancer Lett; 2015 Apr; 359(1):9-19. PubMed ID: 25597786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting antioxidants for cancer therapy.
    Glasauer A; Chandel NS
    Biochem Pharmacol; 2014 Nov; 92(1):90-101. PubMed ID: 25078786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive oxygen species and cancer paradox: To promote or to suppress?
    Galadari S; Rahman A; Pallichankandy S; Thayyullathil F
    Free Radic Biol Med; 2017 Mar; 104():144-164. PubMed ID: 28088622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox control of cancer cell destruction.
    Hegedűs C; Kovács K; Polgár Z; Regdon Z; Szabó É; Robaszkiewicz A; Forman HJ; Martner A; Virág L
    Redox Biol; 2018 Jun; 16():59-74. PubMed ID: 29477046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding of ROS-Inducing Strategy in Anticancer Therapy.
    Kim SJ; Kim HS; Seo YR
    Oxid Med Cell Longev; 2019; 2019():5381692. PubMed ID: 31929855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive oxygen species (ROS) in cancer pathogenesis and therapy: An update on the role of ROS in anticancer action of benzophenanthridine alkaloids.
    Khan AQ; Rashid K; AlAmodi AA; Agha MV; Akhtar S; Hakeem I; Raza SS; Uddin S
    Biomed Pharmacother; 2021 Nov; 143():112142. PubMed ID: 34536761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The redox biology network in cancer pathophysiology and therapeutics.
    Manda G; Isvoranu G; Comanescu MV; Manea A; Debelec Butuner B; Korkmaz KS
    Redox Biol; 2015 Aug; 5():347-357. PubMed ID: 26122399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Oncogenic Nuclear Factor Kappa B Signaling with Redox-Active Agents for Cancer Treatment.
    Fouani L; Kovacevic Z; Richardson DR
    Antioxid Redox Signal; 2019 Mar; 30(8):1096-1123. PubMed ID: 29161883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox Potential and ROS-Mediated Nanomedicines for Improving Cancer Therapy.
    Glass SB; Gonzalez-Fajardo L; Beringhs AO; Lu X
    Antioxid Redox Signal; 2019 Feb; 30(5):747-761. PubMed ID: 28990403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental therapeutics: targeting the redox Achilles heel of cancer.
    Cabello CM; Bair WB; Wondrak GT
    Curr Opin Investig Drugs; 2007 Dec; 8(12):1022-37. PubMed ID: 18058573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary phytochemicals with anti-oxidant and pro-oxidant activities: A double-edged sword in relation to adjuvant chemotherapy and radiotherapy?
    Fernando W; Rupasinghe HPV; Hoskin DW
    Cancer Lett; 2019 Jun; 452():168-177. PubMed ID: 30910593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive oxygen species in cancer: Current findings and future directions.
    Nakamura H; Takada K
    Cancer Sci; 2021 Oct; 112(10):3945-3952. PubMed ID: 34286881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambidextrous Approach To Disrupt Redox Balance in Tumor Cells with Increased ROS Production and Decreased GSH Synthesis for Cancer Therapy.
    Kou L; Sun R; Xiao S; Zheng Y; Chen Z; Cai A; Zheng H; Yao Q; Ganapathy V; Chen R
    ACS Appl Mater Interfaces; 2019 Jul; 11(30):26722-26730. PubMed ID: 31276364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic strategies by modulating oxygen stress in cancer and inflammation.
    Fang J; Seki T; Maeda H
    Adv Drug Deliv Rev; 2009 Apr; 61(4):290-302. PubMed ID: 19249331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROS signalling in the biology of cancer.
    Moloney JN; Cotter TG
    Semin Cell Dev Biol; 2018 Aug; 80():50-64. PubMed ID: 28587975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ROS Modulator Molecules with Therapeutic Potential in Cancers Treatments.
    Nicco C; Batteux F
    Molecules; 2017 Dec; 23(1):. PubMed ID: 29301225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.